Skip to content

Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiota

To evaluate the safety and efficacy of Ayurvedic Interventions and Analysis of Gut Flora in the cases of Amavata vis-à-vis Rheumatoid Arthritis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028746
Enrollment
100
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M068- Other specified rheumatoid arthritis

Interventions

Intervention1: SHATYADI KASHAYA GHAN VATI: AYURVEDIC HERBAL FORMULATION DOSE- 2VATI (EACH VATI 500MG) TDS DURATION OF THERAPY- 90DAYS ROUTE- ORAL Control Intervention1: VIRECHANA FOLLWOWED BY SHATYADI

Sponsors

AMRIT GODBOLE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group between 30-50 yrs willing to participate for the trial with a diagnosis of rheumatoid arthritis using the ACR 2010. 2.Diagnosed cases of Amavata based on symptoms and signs described in Madhav Nidana. 3.Patients with H/O more than 1year with established disease. 4.Sero positive and Seronegative both cases are included.

Exclusion criteria

Exclusion criteria: 1.Patients not willing to participate. 2.Patients with a short history of less than a year. 3.Patients having severe deformities. 4.Patients of Rheumatic Arthritis, Gouty Arthritis, Infective Arthritis, Osteoarthritis. 5.HIV, Tuberculosis, Hypertension, D.M., and other systemic problems. 6.Pregnant & lactating women 7.Patients with major complications such as extra-articular manifestations are also excluded.

Design outcomes

Primary

MeasureTime frame
IMPROVED DAS28 SCORE AND EULAR SCORETimepoint: AT THE TIME OF REGISTRATION, AT THE TIME OF 1ST FOLLOW-UP AT 30DAYS, AT 2ND FU AT 60DAYS, AT 3RD FU AT 90DAYS.

Secondary

MeasureTime frame
ANTI CCP, IL 17, IL10Timepoint: AT THE TIME OF REGISTRATION AND AT THE COMPLETION OF TRIAL

Countries

India

Contacts

Public ContactDR AMRIT GODBOLE

Institute of Medical Sciences, Banaras Hindu University, Varanasi

singhopbhu@gmail.com09415818732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026